20 (AIDX) Accounts Payables (2024 - 2026)

20 (AIDX) posted Accounts Payables of $980486.0 for Q1 2026, up 12.89% on a QoQ basis from $868545.0 in Q4 2025.

20 (AIDX) Accounts Payables (2024 - 2026) Analysis & Trends

20's Accounts Payables history runs 3 years deep, the most recent figure standing at $980486.0 for Q1 2026.

Quarterly Accounts Payables changed N/A year-over-year to $980486.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $980486.0 (changed N/A YoY) and the FY2025 annual result came in at $868545.0, up 133.29% from the prior year.
Accounts Payables was $980486.0 for Q1 2026 at 20, up from $868545.0 in the prior quarter.
Across five years, Accounts Payables topped out at $980486.0 in Q1 2026 and bottomed at $372303.0 in Q4 2024.
A 3-year average of $740444.7 and a median of $868545.0 in 2025 frame the typical range for Accounts Payables.
Peak annual rise in Accounts Payables reached 133.29% in 2025, while the deepest fall reached 133.29% in 2025.
20's Accounts Payables stood at $372303.0 in 2024, then surged by 133.29% to $868545.0 in 2025, then advanced by 12.89% to $980486.0 in 2026.
Business Quant data shows AIDX's Accounts Payables at $980486.0 in Q1 2026, $868545.0 in Q4 2025, and $372303.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Accounts Payables (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	4.68 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	1.59 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	2.64 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	1.14 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	181.10 Mn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	-
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	2.33 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	3.41 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	1.18 Bn
10	20	3.91 Mn	-313,912.28	62,884.00	980,486.00

Download Data